Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New looks in leukemia.

B G Leventhal

    Cancer
    |March 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Immunologic markers aid in diagnosing acute leukemia, identifying T-cell acute lymphoblastic leukemia and aggressive disease subtypes. These markers may help predict relapse and define cure by detecting minimal residual disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study.

    Journal of pediatric hematology/oncology·1998
    Same author

    Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up.

    Medical and pediatric oncology·1997
    Same author

    Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.

    Clinical cancer research : an official journal of the American Association for Cancer Research·1996
    Same author

    Vesiculated erythrocytes as a determination of splenic reticuloendothelial function in pediatric patients with Hodgkin's disease.

    Journal of pediatric hematology/oncology·1995
    Same author

    Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.

    Cancer·1995
    Same author

    With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group study.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1993
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    Same journal

    Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

    Cancer·2026
    Same journal

    Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

    Cancer·2026
    Same journal

    Pediatric cancer survival in the United States from 2001 to 2021.

    Cancer·2026
    Same journal

    Updates on intratumoral therapies in melanoma.

    Cancer·2026
    Same journal

    Correction to "Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025".

    Cancer·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Immunologic markers are now available for acute leukemia diagnosis.
    • Most patients diagnosed with acute lymphoblastic leukemia exhibit blast cells reacting with antihuman T antisera.
    • Approximately 20% of patients present with blast cells forming E rosettes, often associated with high white counts and aggressive disease.

    Purpose of the Study:

    • To investigate the utility of immunologic markers in acute leukemia.
    • To identify tumor-associated antigens in acute leukemia.
    • To correlate antigenic markers with prognosis and disease management.

    Main Methods:

    • Utilizing antihuman T antisera to identify blast cell reactivity.
    • Assessing E rosette formation by blast cells.

    Related Experiment Videos

  • Employing antisera raised in other species to detect leukemia-associated antigens.

    • Main Results:

    • Most acute lymphoblastic leukemia cases show T-cell markers.
    • E rosette-forming blast cells are linked to aggressive disease.
    • Antisera can distinguish myeloid from lymphoid leukemias and correlate with prognosis.

    Conclusions:

    • Immunologic markers offer valuable insights into acute leukemia subtypes and prognosis.
    • Antigenic markers can detect minimal residual disease, aiding in relapse prediction and cure definition.
    • Further research is needed to understand immune manipulations for achieving cure.